Home/Filings/4/0001567619-22-013789
4//SEC Filing

KANGO SUJAY 4

Accession 0001567619-22-013789

CIK 0001262104other

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 4:19 PM ET

Size

6.7 KB

Accession

0001567619-22-013789

Insider Transaction Report

Form 4
Period: 2022-07-05
KANGO SUJAY
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-07-05+87,50087,500 total
    Exercise: $0.54Exp: 2032-07-05Common Stock (87,500 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $2.69Exp: 2031-11-22Common Stock (58,334 underlying)
    58,334
Footnotes (2)
  • [F1]The options will vest in equal monthly installments over twelve months.
  • [F2]25,000 options will vest in equal monthly installments over thirty-six months from November 22, 2021 and 33,334 options shall vest in equal monthly installments over twelve months from November 22, 2021.

Documents

1 file

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeother

Related Parties

1
  • filerCIK 0001336503

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:19 PM ET
Size
6.7 KB